Results 181 to 190 of about 36,992 (256)

Identification of key genes modules linking brain aging signatures and COVID-19-associated cognitive impairment. [PDF]

Virus Res
Xie C, Zhao Y, Wang B, He T, Chen J, Wu X.   +5 more
europepmc   +1 more source

Primary Liver Cancer Trends Worldwide and in China: Analysis of GLOBOCAN 2022 Data and Disease Management Implications

Portal Hypertension &Cirrhosis, EarlyView.
Primary liver cancer remains a major global health burden, with China accounting for over 40% of cases. The predominant etiology is shifting from viral hepatitis to metabolic dysfunction‐associated steatotic liver disease (MASLD), while aflatoxin exposure and unhealthy lifestyles remain important contributors. Comprehensive control strategies—including
Jiayan Yan, Jiayi Wang, Jian Fan, Xinyi Cui, Yuxi Zhang, Xinrong Yang, Qiang Gao, Zhenbin Ding, Zhaoyou Tang, Jia Fan, Dan G. Duda, Ao Huang, Jian Zhou   +12 more
wiley   +1 more source

Equivalent efficacy of left versus right hemisphere accelerated intermittent theta burst stimulation for major depressive disorder. [PDF]

Front Psychiatry
Quinn DK, Upston J, Jones TR, Olmstead TA, Yang J, Reyes S, MacDonald S, Littleton A, Win A, Bowers-Wu DH, Lee JG, Huynh P, DeBurlo RT, Velasco A, Nakip A, Richardson ER, Davis JR, Hazlewood S, Garcia CA, Ojeda CJ, Luo K, David J, Gibson BC, Nikogosyan GM, Hager BW, Farrar D, Myers O, Vakhtin AA, Abbott CC.   +28 more
europepmc   +1 more source

Fast Quantitative Evaluation of the Amelioration Effect in MASLD During Semaglutide Treatment Using Ultrasound‐Derived Fat Fraction and Fat‐to‐Muscle Ratio

Portal Hypertension &Cirrhosis, EarlyView.
Metabolic dysfunction‐associated steatotic liver disease (MASLD) is a chronic liver disease. Research into a feasible, rapid, and effective assessment method is crucial for evaluating the therapeutic effects of semaglutide in MASLD. This prospective study utilized ultrasound‐derived fat fraction measurement and fat‐to‐muscle ratio to evaluate hepatic ...
Yunlin Huang, Ruping Yang, Ying Wang, Xiu‐Yun Lu, Li Wei, Rui Cheng, Juan Cheng, Yijie Qiu, Shiwen Wang, Bo Li, Yi Dong   +10 more
wiley   +1 more source

Update on the HDV seroprevalence and genotype distribution among patients positive for HBsAg referred to a National Reference Laboratory in Cameroon between January 2019 and December 2020. [PDF]

IJID Reg
Mfonkou JDT, Foupouapouognigni Y, Gerber A, Brichler S, Legal F, Modiyinji AF, Lissock F, Ngono L, Onana B, Gordien E, Njouom R.   +10 more
europepmc   +1 more source

From HBV to MASLD Cirrhosis: Mechanistic Insights and Therapeutic Strategies

Portal Hypertension &Cirrhosis, EarlyView.
This review examines the epidemiological shift from hepatitis B virus (HBV) to metabolic dysfunction‐associated steatotic liver disease (MASLD) as the leading cause of cirrhosis globally. It highlights the distinct pathogenic mechanisms between HBV and MASLD cirrhosis and discusses evolving diagnostic tools and therapeutic strategies tailored to the ...
Hanqi Yu, Hongfan Ding, Yang Huang, Haoze Cao, Yuan Ding, Weilin Wang   +5 more
wiley   +1 more source

Antineutrophil Cytoplasmic Antibody (ANCA) Vasculitis, Fatigue, and Treatment With Avacopan: A Case Series. [PDF]

Cureus
Schulze C.
europepmc   +1 more source

Key Skills; Rhetoric, Reality and Reflection [PDF]

, 2004
Tariq, Vicki
core  

Uric Acid in Metabolic Dysfunction‐Associated Steatotic Liver Disease

Portal Hypertension &Cirrhosis, EarlyView.
MASLD is the most prevalent chronic liver disease worldwide, yet effective pharmacological treatments remain limited. Hyperuricemia is now recognized as a key driver of hepatic steatosis, inflammation, and fibrosis, with elevated serum uric acid levels independently predicting hepatocellular carcinoma and liver‐related mortality.
Rong Wang, Zhenyu Liu, Jun Lin, Weijing Zhang, Xianzhi Liu, Tong Zhang   +5 more
wiley   +1 more source

A high content (30%) stable doxycycline hyclate drinking-water solution for broilers: preparation, stability, and bioequivalence. [PDF]

Front Vet Sci
Liu Z, Jiao X, Xie L, Ren W, Lv L, Du J, Huang X.   +6 more
europepmc   +1 more source